Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Fintel reports that on October 2, 2024, B. Riley Securities downgraded their outlook for Gritstone bio (NasdaqGS:GRTS) from Buy to Neutral. Analyst Price Forecast Suggests 1,880.58% Upside As of ...
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Gritstone bio, Inc.
GRTS COVID-19 vaccine can use two components, a chimpanzee adenovirus ((ChAd)) and self-amplifying mRNA (samRNA). Pfizer (PFE) and BioNTech (BNTX) as well as Moderna (MRNA) both used mRNA in their ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...